Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Андрей Анатольевич Воронко, Алла Ивановна БуженкоfiledCriticalАндрей Анатольевич Воронко
Priority to UAU201000839UpriorityCriticalpatent/UA51002U/en
Publication of UA51002UpublicationCriticalpatent/UA51002U/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
A method for correcting the disordered carbohydrate metabolism in metabolic syndrome (MS) provides for the examination of the patients and diagnosis of MS and the disordered carbohydrate metabolism. The drugs correcting carbohydrate metabolism are used. The list of the drugs being administered is not limited to sulfanyl urea derivatives, biguanides, inhibitors of α-glycosidases, and thiazolidine diones. The following drugs are also used: glinides, incretin mimetics, amilinomimetics, inhibitors of dipeptidyl-peptidase-4, double (α/γ) agonists of nuclear peroxisomal proliferation-activation receptor, and antagonists of canabioid receptors type I.
UAU201000839U2010-01-282010-01-28Method for correcting disordered carbohydrate metabolism in metabolic syndrome
UA51002U
(en)
Use of a pharmaceutically active h2 relaxin in the manufacture of medicaments for treating dyspnea associated with acute heart failure and acute decompensated heart failure